The S-ICD System has two main components: (1) the pulse generator, which powers the system, monitors heart activity, and delivers a shock if needed, and (2) the electrode, which enables the device to sense the cardiac rhythm and serves as a pathway for shock delivery when necessary. Both components are implanted just under the skin-the generator at the side of the chest, and the electrode beside the breastbone. Implantation with the S-ICD System is straightforward and can be done using only anatomical landmarks which removes the need for fluoroscopy (an X-ray procedure that is required for standard leads to be placed in the heart).
The S-ICD System is intended to provide defibrillation therapy for the treatment of life-threatening ventricular tachyarrhythmias in patients who do not have symptomatic bradycardia, incessant ventricular tachycardia, or spontaneous, frequently recurring ventricular tachycardia that is reliably terminated with anti-tachycardia pacing.
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
The U.S. Food and Drug Administration granted regulatory approval for the S-ICD System in September of 2012. To date, more than 2,000 devices have been implanted in patients around the world.
"The S-ICD System is like having an emergency response team on your chest," says Dr. Le. "The S-ICD System is a valuable new treatment option for both primary and secondary prevention for patients at risk of sudden cardiac arrest. In addition, it provides an important alternative for patients that are not candidates for conventional transvenous ICD systems."
For more information about Orange Coast Memorial Medical Center or the S-ICD System, please call 714-378-7207 or visit our website at www.memorialcare.org/heart.
Back to HCB News
